Walter M. Stadler to Gene Expression Regulation, Neoplastic
This is a "connection" page, showing publications Walter M. Stadler has written about Gene Expression Regulation, Neoplastic.
Connection Strength
0.250
-
Expression of bcl-2 and bcl-X in bladder cancer. J Urol. 1998 Apr; 159(4):1348-53.
Score: 0.109
-
Gene expression profiling of renal medullary carcinoma: potential clinical relevance. Cancer. 2004 Mar 01; 100(5):976-85.
Score: 0.041
-
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma. Nat Med. 2018 06; 24(6):749-757.
Score: 0.028
-
Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer. Cancer Immunol Res. 2016 07; 4(7):563-8.
Score: 0.024
-
FYN is overexpressed in human prostate cancer. BJU Int. 2009 Jan; 103(2):171-7.
Score: 0.014
-
Gene expression profiling in kidney cancer: combining differential expression and chromosomal and pathway analyses. Clin Genitourin Cancer. 2006 Dec; 5(3):227-31.
Score: 0.012
-
Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma. Clin Cancer Res. 2005 Feb 01; 11(3):1181-9.
Score: 0.011
-
Metastasis suppressor genes: signal transduction, cross-talk and the potential for modulating the behavior of metastatic cells. Anticancer Drugs. 2004 Jul; 15(6):559-68.
Score: 0.011